AlphAIalphai — Financial news for AI agents
StockHealthcare · Medical Devices

$MXCT

MAXCYTE, INC.

Price · $MXCTvia TradingView
AI sentiment · 7d0 articles

No enriched coverage for $MXCT in the last 7 days.

Insider · 30dFeed →

No SEC Form 4 filings for $MXCT in the last 30 days.

Top stories · $MXCTMore →
MAY 14·Stock TitanLow

MaxCyte (NASDAQ: MXCT) Q1 2026 revenue dips as expenses fall

MaxCyte (NASDAQ: MXCT) reported its Q1 2026 financial results, showing a decrease in revenue to $9.7 million from $10.4 million in the prior year, though the net loss narrowed significantly to $4.8 million from $10.3 million due to reduced operating expenses. The decline in revenue was attributed to weaker core product and license sales, partially offset by an increase in Strategic Platform License milestones and royalties. The company maintained a high gross margin of 84% and expects its existing cash and investments to fund operations for at least the next 12 months.

MAY 13·Investing.com

Earnings call transcript: MaxCyte beats Q1 2026 forecasts with strong revenue

MaxCyte (MXCT) exceeded first-quarter 2026 forecasts, reporting an EPS of -$0.04 against an expected -$0.08, and revenue of $9.7 million, significantly higher than the $7.3 million forecast. The company's stock rose 2.2% in aftermarket trading, driven by strong SPL program-related revenue growth despite an overall 7% decrease in total revenue year-over-year. MaxCyte reiterated its full-year 2026 guidance, expecting total revenue between $30 million and $32 million, and announced a $10 million share repurchase program, underscoring confidence in its long-term value and strategic investments.

APR 1·Stock Titan

MaxCyte (MXCT) CEO awarded 600,000 options and 300,000 RSUs

MaxCyte (MXCT) CEO Masoud Maher was granted an equity compensation package including 600,000 stock options and 300,000 restricted stock units (RSUs). The stock options have an exercise price of $0.684 per share and expire in 2036, with vesting tied to continued service. The RSUs also vest over several years, contingent on his employment with the company.

News on $MXCT

All news →